Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Tardive Dyskinesia and Affective Disorders Nuances in the 21st Century
  • CME
  • CE

Credits Available
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Physician Assistants: maximum of 1.0 hour of AAPA Category I (Preapproved) credit
Psychologists: 1.0 APA CE Credit
Released: February 22, 2021 Expiration: February 22, 2022
Start Activity
Provided by Postgraduate Institute for Medicine

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by independent educational grants from
Neurocrine Biosciences
Sunovion
Sanjay Gupta, MD

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe prevalence of TD in affective disorders
  • Review the AIMS examination for TD
  • Discuss evidence-based treatments for TD

Information on this Educational Activity

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Faculty

Sanjay Gupta, MD

Clinical Professor
Department of Psychiatry
SUNY at Buffalo Jacobs School of Medicine
Chief Medical Officer
BryLin Behavioral Health System
Buffalo, New York

Sanjay Gupta, MD, has disclosed that he has received fees for non-CME/CE services from AbbVie, Alkermes, Indivor, Intra-Cellular Therapies, Janssen, Neurocrine Biosciences, Otsuka, and Sunovion.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

The Global Medical Education planner and manager, Prakash Masand, MD, has disclosed the following:

Consultant: Acadia, Allergan, Eisai, Intra-Cellular Therapies, Lundbeck, Sunovion, Takeda

Research Support: Allergan

Speaker’s Bureau: Allergan, Intra-Cellular Therapies, Lundbeck, Sunovion, Takeda

Shareholder: Centers of Psychiatric Excellence (COPE), Global Medical Education

The PIM planners and managers have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Target Audience

This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists and psychologists engaged in the care of patients with mood disorders.

Joint Accreditation Statement

 

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour. Designated for 0.5 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.

California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 1 contact hour.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.\

Universal Activity Number –JA4008162-9999-21-2601-H01-P

Type of Activity: Knowledge

AAPA Credit Designation Statement
This activity is designated for 1 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Continuing Psychologist Education
Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP).  The APA CEP Office maintains responsibility of the program.

Credit Designation
This program offers 1.0 continuing education credit for psychologists.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 22, 2021, through February 22, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Tardive Dyskinesia and Affective Disorders Nuances in the 21st Century
  • CME
  • CE

Loading...
This webcast reviews tardive dyskinesia and affective disorders nuances in the 21st century.
Sanjay Gupta, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Physician Assistants: maximum of 1.0 hour of AAPA Category I (Preapproved) credit
Psychologists: 1.0 APA CE Credit
Released: February 22, 2021 Expiration: February 22, 2022

Related Content

Slides from a presentation that educates clinicians on Huntington disease and the management of chorea

Victor W. Sung, MD Released: September 17, 2021

Slides from a presentation on strategies to improve treatment-resistant depression from a global perspective.

Siegfried Kasper, MD Released: September 3, 2021

Slides from a presentation that educates clinicians on strategies to improve depression treatment and future directions of treatment.

Pim Cuijpers, PhD Released: September 3, 2021

Slides from a presentation that educates clinicians on evaluation of mental health-related apps, patient privacy, and informed decision-making.

John Torous, MD Released: September 2, 2021
Provided by Postgraduate Institute for Medicine

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by independent educational grants from
Neurocrine Biosciences
Sunovion

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue